Bevacizumab in Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Avastin and Taxotere for Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)
- Status
- COMPLETED
- Phase
- PHASE2
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2